Physician profile
Thomas Liu
NPI 1245270255
$1,758.34
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $771 · 2020: $199 · 2021: $70.12 · 2022: $153 · 2023: $354 · 2024: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $625.35 | 2019-2024 | Xifaxan |
| Abbvie INC. | $273.79 | 2019-2024 | |
| Janssen Biotech, INC. | $139.48 | 2019-2023 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $115.26 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $89.18 | 2019-2023 | Linzess |
| Allergan, INC. | $55.57 | 2019 | |
| Pfizer INC. | $47.21 | 2023-2024 | |
| Celgene Corporation | $46.94 | 2022-2023 | Zeposia |
| Astellas US LLC | $44.02 | 2024 | Izervay |
| Qol Medical, LLC | $39.18 | 2021-2023 | Sucraid |
| Merck Sharp & Dohme LLC | $34.61 | 2019 | |
| Braintree Laboratories, INC. | $34.07 | 2019 | |
| Sandoz INC. | $29.95 | 2023 | Hyrimoz |
| Nestle Healthcare Nutrition INC. | $28.19 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $26.02 | 2024 | Dupixent |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $23.11 | 2020 | |
| Lucid Diagnostics INC. | $22.28 | 2023 | |
| Gilead Sciences, INC. | $18.51 | 2019 | |
| Redhill Biopharma INC. | $18.09 | 2022 | |
| Shire North American Group INC | $17.28 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.63 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.